The House’s Cut is Going Up
Motley Fool Money
00:00
The Rise of GLP-1 Agonists: New Frontiers in Weight Management
This chapter explores the advent and functioning of GLP-1 agonists like Ozempic in weight loss and their effects on insulin and appetite regulation. It also addresses the potential for these drugs to influence addiction treatment, juxtaposed with cautions drawn from past medications and the scrutiny of current FDA oversight.
Play episode from 12:03
Transcript
